Interstitial cystitis: Etiology, diagnosis, and treatment

Canadian Family Physician

Volumn 46, Issue DEC., 2000, Pages 2430-2440

  Nickel, J C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIUROLITHIASIS AGENT; ARGININE; BCG VACCINE; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; DIMETHYL SULFOXIDE; FLAVOXATE; HEPARIN DERIVATIVE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYALURONIC ACID; HYDROXYZINE; NIFEDIPINE; OPIATE AGONIST; OXYBUTYNIN; PENTOSAN POLYSULFATE; PIPERAZINE DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; SPASMOLYTIC AGENT; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALYTIC METHOD; ARTICLE; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DIET THERAPY; DRUG EFFECT; DRUG EFFICACY; EVIDENCE BASED MEDICINE; GENERAL PRACTICE; HUMAN; INTERSTITIAL CYSTITIS; MEDICAL INFORMATION; MEDICAL LITERATURE; MORBIDITY; PATHOGENESIS; SEX DIFFERENCE; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADMINISTRATION, INTRAVESICAL; ALGORITHMS; AUTOIMMUNE DISEASES; BACTERIAL INFECTIONS; CYSTITIS, INTERSTITIAL; CYSTOSCOPY; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; MALE; POTASSIUM; QUALITY OF LIFE; URINARY BLADDER; URINARY BLADDER, NEUROGENIC;

EID: 0034491181     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Interstitial cystitis: Clinical and endoscopic features
2. Interstitial cystitis: An inflammatory bladder syndrome of unknown etiology
3. Interstitial cystitis: A common cause of painful bladder
4. Interstitial cystitis
5. Epidemiology of interstitial cystitis
6. Interstitial cystitis: Successful management by increasing urinary voiding intervals
7. Prevalence of interstitial cystitis in the United States
8. Interstitial cystitis in the Netherlands: Prevalence, diagnostic criteria and therapeutic preferences
9. Epidemiology of interstitial cystitis: A population based study
10. Successful therapy of interstitial cystitis with pentosanpolysulfate
11. Bladder surface glycosaminoglycans. Efficient mechanism of environmental adaptation
12. Bladder surface glycosaminoglycans: An epithelial permeability barrier
13. Glycosaminoglycans on the surface of the human urothelium: A preliminary report
14. Decreased expression of glycoprotein component of bladder surface mucin (GP1) in interstitial cystitis
15. Ultrastructural visualization of human bladder mucus
16. Ultrastructural study of an antibody stabilized bladder surface: A new perspective on the elusive glycosaminoglycan layer
17. Relative efficacy of various exogenous glycosaminoglycans in providing a bladder surface permeability barrier
18. The bladder mucus (glycosaminoglycan) layer in interstitial cystitis
19. The bladder glycosaminoglycan/mucin layer in interstitial cystitis: The Kingston experience
20. Distribution changes of bladder mucosal surface molecules in interstitial cystitis
21. Epidemiology of interstitial cystitis: 2
22. Dormant microbes in interstitial cystitis
23. Absence of bacterial DNA in the bladder of patients with interstitial cystitis
24. Polymerase chain reaction amplification of bacterial 16S rRNA genes in interstitial cystitis and control patient bladder biopsies
25. Bladder antibodies in interstitial cystitis
26. Specific auto-antibodies in interstitial cystitis patients suggest an auto-immune etiology
27. Mast cells and interstitial cystitis
28. The enigma of interstitial cystitis - An autoimmune disease?
29. Distinctive ultrastructural pathology of nonulcerative interstitial cystitis: New observations and their potential significance in pathogenesis
30. Interstitial cystitis: A critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis
31. The diagnosis of interstitial cystitis
32. Diagnosis of interstitial cystitis
33. A rare type of bladder ulcer in women: Report of cases
34. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987
35. The Interstitial Cystitis Data Base Study: Concepts and preliminary baseline descriptive statistics
36. The diagnosis of interstitial cystitis revisited: Lessons learned from the National Institutes of Health Interstitial Cystitis Database study
37. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation
38. Baseline associations among pathologic features and patient symptoms in the National Interstitial Cystitis Data Base (ICDB) study
39. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis
40. An assessment of the use of intravesical potassium in the diagnosis of interstitial cystitis
41. Potassium leak test predicts outcome in interstitial cystitis
42. Potassium leak test predicts outcome in interstitial cystitis
43. Self care regimens for patients with interstitial cystitis
44. Behavioral therapy for the treatment of refractory interstitial cystitis
45. Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study
46. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate
47. A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease
48. Analysis of long-term Elmiron therapy for interstitial cystitis
49. Long-term experience with pentosanpolysulfate in interstitial cystitis
50. Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: A meta-analysis
51. Hydroxyzine in the treatment of interstitial cystitis
52. Use of amitriptyline in interstitial cystitis
53. Amitriptyline in the treatment of interstitial cystitis
54. Clinical and immunological response to nifedipine for the treatment of interstitial cystitis
55. Improvement in interstitial cystitis symptom scores during treatment with oral L-argenine
56. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis
57. Cimetidine in the treatment of interstitial cystitis
58. Intravesical 50% dimethyl sulfoxide (Rimso-50) in treatment of interstitial cystitis
59. A control study of dimethyl sulfoxide in interstitial cystitis
60. Heparin in the treatment of interstitial cystitis
61. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis
62. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis
63. Treatment of refractory interstitial cystitis
64. Prolongation of response to DMSO by heparin maintenance
65. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis
66. The efficacy of intravesical Tice strain bacillus Calmette-Guérin in the treatment of interstitial cystitis: A double-blind, prospective, placebo controlled trial
67. The efficacy of intravesical bacillus Calmette-Guérin in the treatment of interstitial cystitis: Long-term follow up
68. Surgical management of interstitial cystitis
69. Pelvic pain without pelvic organs
70. Long term follow-up demonstrates a markedly increased ureteroenteric anastomotic stricture rate in interstitial cystitis patients undergoing urinary diversion